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S urgical training has traditionally incorporated time-honored rules that are fundamental in providing best-practiceapproaches inoncology.Ofutmost importance is the
goal of completely removing the cancer because positive margins
of surgical resectioncontribute to increased local recurrenceandde-
creased survival rates.1 Also, emphasis is given to the careful han-
dling of the cancerous lesions and the surrounding tissues, primar-
ily tominimize dispersion of cancer cells. However, what has come
under recent scrutiny is the longstanding dictum not to surgically
violate visible tumor during the extirpative process. It has been
taught that cutting through gross tumor during an operation in-
creases the risk of spreading viable cancer cells beyond the tumor
and into thesurroundingnormal tissue. Suchamaneuvermaycause
cancer cells to adhere to surgical instruments and subsequentlybe-
come inadvertently implanted into thesurrounding tissuebymeans
of direct contact of the contaminated object. While documenta-
tionofthisphenomenonisnotprominent inthe literature, inthehead
and neck literature a case report alludes to surgical implantation–
related chestwall tumor followingpectoralismajor flap reconstruc-
tion for a pharyngeal cancer defect.2 Presumably, tumor cells can
beseededbycontaminated instrumentsused in theextirpativepro-
cess within the adjacent donor site created to reconstruct a defect
following cancer resection. Such events, albeit anecdotal, under-
score the importanceof theconcept for enbloc resection,which for
more than a century has remained a widely accepted principle in
surgical oncology.
Although theprinciple of enbloc resection remains important,
its application for surgical extirpationof cancerwithin somesites of
theheadandneck isnotalways feasible. Forexample,within thena-
sopharynx, anterior and lateral skull base, and sinonasal region, sur-
geons often find it difficult to adhere to this rule. Knowing that the
fundamental premise is to remove the tumor with clear margins,
head and neck surgeons have traditionally strived to achieve such
resections for removing tumors as single intact specimens. How-
ever, too often the pathologist receives specimens that have been
removed inmultiple pieces.With some reservations, it is likely that
such experiences have led to the acceptance of piecemeal removal
of cancer in select situations when monobloc resection is not fea-
sible or practical and as long as complete resection is achieved
with clear margins.
Exactly when the attitude of accepting piecemeal removal of
cancer began remains unclear. The evidence points to a gradual
evolution. The early examples of tumor cut-through evolvedunder
circumstances thatweremoresubtle.Forexample, thesurgical tech-
nique of Mohs for cutaneous malignant neoplasms has been prac-
ticedbydermatologists formore thanhalf acentury. Inprinciple, this
technique involves serial excisions parallel to the tumor margins
until there is clearance of cancer cells. Although the intent is not to
deliberately cut through gross disease, the approachdoes increase
this risk because of the narrow margin being attempted to con-
serve tissue.3 Justification of this narrow-margin approach rather
than committing to the traditional wide margin is based on the
judicious use of “real-time” histologic analysis by the dermatologic
surgeon using frozen section technique to serially assess all surgi-
cal margins. In other words, because the margins were taken tan-
gentially rather than perpendicularly, and examined personally by
the surgeon at the time of the excision, the proportion of the total
margin being examined under the microscope approached 100%.
Also, it should be noted that the technique of Mohs surgery was
originallydesigned for relatively indolentbasal cell carcinomasof the
skin. Later he applied it toother typesof skin cancer using theorigi-
nal fixed-tissue technique for extensive, complicated cancers that
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invade into or around bony structures, for cancers invading the
erectile tissues of the penis, and for melanoma. The fresh-tissue
technique was recommended for almost all other cutaneous
cancers.4 Nonetheless, it could be argued that Mohs chemosur-
gery and its subsequent modifications does represent an early
example of cancer surgery in which the basic principle of avoiding
tumor cut-through was not the strategy for complete tumor extir-
pation. Frozen sectionsof surgicalmargins are alsoused inmanage-
mentofmucosalmalignant neoplasms, particularly in oral andpha-
ryngeal cancer. However, unlike the smaller cutaneous cancers,
margin analysis of these lesions requires a systematic evaluation of
larger surfaces usually comprising submucosal tissue andmuscula-
ture in addition to the mucosal epithelium. While tangential sec-
tion has some role to play in the process, most pathologists find it
more practical to sample select margins of larger specimens using
perpendicular sectioning. Hence, the proportion of the total mar-
gin examined under the microscope is less than in the Mohs ap-
proach. Reassuring for the techniques of margin analysis, 1 study
reported that patients with positive margins who underwent im-
mediate repeated resection seemed to have the same survival
rate as patientswho had negativemargins after the firstmonobloc
tumor resection.5
Treatment Outcomes
With regard to the seminal publications in which planned surgical
transgression of tumor-bearing tissue is routinely used, an impor-
tantexample is sinonasal cancer, inwhichnovelprotocolshavebeen
developed that incorporated tumor debulking.6 Sato et al6
pioneered a “trimodality” protocol for advanced sinonasal cancer.
Although the regimen included 3 treatment modalities, the surgi-
cal component involved debridement of tumor from the maxillary
sinusrather thanthestandardtreatmentofenblocresection.Among
the 57 cases of carcinoma treated, 22 patients required no further
treatment at the end of the protocol. Among the 19 patients with
persisting tumor at the end of the therapy, partial resection of the
maxilla or intracavitary radiation therapy was effective in eradicat-
ing the residueof the tumor inall of them.Total resectionof themax-
illa was not required even in the advanced cases, which increased
the number of patients who were rehabilitated successfully.
Compared with a prior group of patients, this therapy reduced the
rateof local recurrencesandconsequently improvedthesurvival rate.
More recent reports using variations of the trimodality therapy ap-
proachwith piecemeal removal of residual cancer have also shown
improved results in terms of disease control, as well as organ
preservation.7,8 Whereas the more recent studies used modifica-
tions involving different chemotherapy agents and methods of in-
fusion, the techniques forpiecemeal removalhavealsoevolvedfrom
debulking to systematic and comprehensive piecemeal removal
using frozen section control to ensure clear margins.8
Realizing that en bloc removal of advanced sinonasal cancers
involving the anterior cranial base is impractical in some cases,
other investigators began to change the surgical technique for
exposing such tumors using approaches that were transfacial or
transcranial only. In a transfacial series9 of 308 patients who had
undergone craniofacial resection for sinonasal neoplasia, the sub-
set with malignant disease had a 5-year actuarial survival of 59%
at 5 years. In a case series reported by Blacklock et al,10 9 patients
underwent transcranial-only surgery for malignant tumors, all of
whom remained free of disease during the follow-up period. Fur-
thermore, this approach proved to be an effective technique for
reconstruction without the need for free-tissue transfer.
Although the piecemeal resection technique was viewed as
nonconventional and not widely accepted at the time as standard
of care, such procedures subsequently proved to be an effective
treatment for selected patients with sinonasal cancer in reports
by others.6,8,10
Endoscopic sinus surgeons subsequently began to remove se-
lectedcancersof smallervolumeusing the transnasal approach,usu-
allywithout facial incisions. Between 1989and 1999, Stammberger
et al11 treated 43 patients with invasive and/or destructive tumors
of theparanasal sinuses and theanterior skull base strictly using the
endoscopic transnasal technique. Whereas the first patients were
approached with a palliative intention, subsequently selected pa-
tients were treatedwith curative intention. Histologically, patients
with various differentiated carcinomas were operated on (n = 18),
as well as patients withmalignant melanoma (n = 5), esthesioneu-
roblastoma (n = 8), clivus chordoma (n = 3), immature teratoma
(n = 1), and leiomyosarcoma (n = 1). Their first results indicated that
survival outcomewas at least equal to that of standard external ap-
proaches but with excellent functional outcomes and significantly
better overall quality of life.
Ina largerendoscopicsinusseries,LundandWei12 reportedtheir
experiencewith 140patientswith amean follow-upof 60months.
Eighteendifferentmalignanthistopathologic subtypeswere repre-
sented, with olfactory neuroblastoma (n = 36), malignant mela-
noma (n = 33), and adenocarcinoma (n = 19) being the common-
est.Additional radiotherapywasgiven in95casesandchemotherapy
in 49. The overall survival was 84%at 5 years and 69%at 10 years.
The larynx represents another site in which piecemeal tumor
removalwasdeveloped.Steiner13published treatmentoutcomesof
240 patients treated between 1979 and 1985 with curative intent
for cancer of the larynx through a transoral laser resection ap-
proach. Therewere 159patientswith glottic cancer (Tis, 29; T1, 96;
T2, 34). The local recurrence ratewas only6%,with 1 patient need-
inga total laryngectomy.Theoverall 5-year survival ratewas86.5%.
Among the 81 patients with supraglottic tumors, 58 patients were
in tumor category pT2 (38 with glottic extension), 17 patients had
pT3, and 6, pT4 tumors. The 5-year overall survival for supraglottic
cancers was 59%, with 22% local recurrence and 6 cases of total
laryngectomy.
In a concurrent study, Rudert and Werner14 reported 47
patients with variously sized supraglottic tumors and 114 patients
with early glottic cancers treated between 1979 and 1993.
Although 10 patients with glottic tumors developed recurrences,
curative treatmentwas possiblewith either repeated laser surgery
(3 cases), radiation therapy (3 cases), or salvage laryngectomy
(3 cases). Among the 30 patients with supraglottic lesions treated
for cure, 24 remained free of disease, 2 patients died from second-
ary cancers, and 3 patients died from their tumors.
The same investigatorswhobegan using transoral lasermicro-
surgerywith its piecemeal technique for excising carcinomasof the
larynx subsequently extended its application to the hypopharynx,
oropharynx,andoral cavity.Documentationof its suitability for these
additional sites is strongest in the oropharynx. Steiner et al15
reported the outcomes of 48 previously untreated patients with
base-of-tonguesquamouscell carcinomatreated in thismanner.The
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distribution of the T categories was T1, 2%; T2, 25%; T3, 15%; and
T4, 58%; and 94% had stage III to IVa disease. Selective neck dis-
sectionwasperformed in43patients; 23patients underwent post-
operative radiotherapy with or without simultaneous chemo-
therapy. TheKaplan-Meier 5-year local control ratewas85%.There
was no local recurrence in T1 and T2 lesions, but there was a 20%
local recurrence rate in T3 and T4 tumors. The 5-year recurrence-
free andoverall survival rateswere 73%and52%, respectively. The
meanperformancestatusscalescoreswere92%fornormalcyofdiet
and88%forunderstandability of speech. Twenty-onepatients sur-
vivedat least5years after treatmentwitha functional larynx.A later
prospective trial conducted byHaughey et al16 provided confirma-
tion of the transoral laser microsurgery approach for oropharyn-
geal cancer. The data included 204 patients with stage III to IV
tonsil or tongue base cancer, treated between 1996 and 2006 at 3
centers. With a mean follow-up of 49 months, 79.4% of patients
were alive. The 3-year overall survival, disease-specific survival,
and disease-free survival rates were 86%, 88%, and 82%, respec-
tively. The local control rate was 97%, while 87% of patients had
normal swallowingoronlyepisodicdysphagia. Thus, fororopharyn-
geal cancer, these 2 studies along with others have demonstrated
that transoral laser microsurgery as a primary treatment for
advanced oropharyngeal cancer confers excellent survival and
swallowing proficiency.
In thehypopharynx,Steineretal17 treated 129patientswithcar-
cinoma of the piriform sinus with transoral laser microsurgery be-
tween1981and1996.Amongthem,24patientshadpT1,74hadpT2,
17hadpT3, and 14hadpT4disease.Nodestatuswaspositive in68%
of patients. Seventy-five percent of patients had stage III or IV dis-
ease. Forty-twopercentof thepatientswere treatedsolelywith sur-
gery, and 58% underwent surgery and postoperative radio-
therapy.Withamedian follow-upof44months,87%of thepatients
achieved local controlofdisease.The5-yearoverall survival ratewas
71%for stage I and II and47%for stage III and IVdisease. The5-year
recurrence-free survival rates were 95% and 69%, respectively.
Discussion
Theaforementioned treatmentoutcomes for patientswith sinona-
sal, laryngeal, oropharyngeal, and hypopharyngeal cancer inwhich
piecemeal removal was used support the use of surgical tech-
niques that involve tumor transgression in select situations.Of par-
ticular advantage for patients with sinonasal cancer is the endo-
scopicapproach,which involvestheprogressiveremovalof the lesion
whilemaintainingaclearperspectiveof theboundariesbetweennor-
mal anddiseased structures. Theendoscopic intervention typically
starts with tumor debulking with the intent to define the possible
site of origin of the lesion and its relationshipwith the anterior skull
base.18 In laryngeal cancer, the transoral laser microsurgery ap-
proachwas based on the rationale that cutting through viable can-
cer with the laser did not carry the same risk of dispersing cancer
cells as usingaknifeor scissors. Furthermore, the carbondioxide la-
ser may have the added benefit of sealing small lymphatic vessels
when used to cut through viable cancer. Also, the approach using
segmental resection allowed improved visualization of the tumor-
host interface, which better ensured a margin of resection devoid
of cancer. Thus, thepiecemeal removalof cancers involving theglot-
tis, supraglottis, and subsequently other upper aerodigestive tract
sites has led to the development ofwhat has nowbecomemodern
endoscopic surgery for upper aerodigestive tract cancer.
It is important to remember that theword “piecemeal” should
notbe interpretedas thehaphazardremovalofpiecesof tumorwith-
out regard to achieving completeness of removal. It should be in-
terpreted to convey systematic and planned removal of segments
of tumor for better visualization, to facilitate complete resection,
which is theultimategoalof theoperation.Theuseof labeled“maps”
anddifferentially colored inkedmargins isessential to facilitatecom-
municationbetweensurgeonandpathologist in identificationofmar-
gin specimens. Based on treatment results, it appears that margin
control equivalent to traditional techniques of serial sectioning of
enbloc specimens canbe achieved as long as the surgeon is careful
to submit a complete representation of the tumor-host interface
for comprehensive histologic examination of all surfaces.
While the modifications of the en bloc resection of sinonasal
cancers and other skull base malignant tumors represented a
gradual change in practice, the acceptance of tumor cut-through
for transoral resection of laryngeal cancer seems to have evolved
over a shorter time frame. In retrospect, one could argue that this
modification, considered bold at the time, precipitated a paradigm
shift for treating this site-specific cancer. Prior to transoral laser
surgery, the principles of laryngeal cancer excision emphasized the
traditional en bloc technique, whether in the context of conserva-
tion surgery (partial laryngectomy) or whole-organ resection (total
laryngectomy). Of particular note, when endoscopic laryngeal
laser surgery was being pioneered, the initial strategy was to
excise the lesion as a single specimen and avoid tumor cut-
through. As a result, the application of the approach as a primary
treatment was limited to low-volume disease, primarily T1 to T2 of
the vocal cord.19 It was only when colleagues in Germany deviated
from the traditional principle and began to violate the tumor with
multiple laser cuts that it became possible to excise tumors of
higher volume within the glottis and supraglottis.13,14 In addition,
Haughey et al16 and others have taken advantage of this strategy
to excise advanced-stage lesions of the oropharynx using the
transoral laser microsurgery exposure.
When analyzing the treatment results of therapies for ad-
vanced disease that rely on piecemeal removal, one must keep in
perspective the use of adjuvant therapies such as radiation and
chemoradiation.20 When surgical principles for oncology evolved
during the late 19th and early 20th centuries, such adjuvant treat-
mentmodalities did not exist. The principleswere based on the re-
lianceonsurgery alone forproviding thebest chance for cure. Thus,
the surgical violation of gross tumor portending a worse outcome
was of great concern. Although the evolution of combined treat-
ment modalities may have served to mitigate these concerns, it
should be emphasized that their advent was never intended to
change the principle of achieving complete tumor resection.When
complete tumor resection is achieved, similaroncologic resultshave
beendemonstrated inbothenbloc andpiecemeal resectionsof ad-
vanced laryngeal tumors, irrespective of the administration of ad-
juvant treatment.21 Suffice it to say that adjuvant therapies do not
make up for incompletely removed tumors.
Relative to surgery as it was practiced a century ago, it is
important to note that surgical decision making has been
improved because of technical advances in many medical fields,
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including diagnostics and therapeutic modalities. Clearly, the
availability to the head and neck surgeon of instruments to con-
duct endoscopic surgery, laser microsurgery, and robotics has
revolutionized the field. Advances in tumor imaging now permit
surgical planning that essentially eliminates unexpected intraop-
erative findings and allows the surgeon to accurately plan
approaches for removing the disease.
Conclusions
The time-honored rule of never purposefully cutting through can-
cer has changed, but the fundamental concept of completely
removing the tumor with clear margins stands, even if it is not in
continuity. Whether the tumor is removed as a monobloc speci-
men or in a systematic comprehensive piecemeal fashion is not
important, as long as complete removal is accomplished. How-
ever, in select circumstances the advantages of tumor cut-through
outweigh the adverse possibilities. This has been demonstrated in
the treatment of sinonasal, laryngeal, oropharyngeal, and hypo-
pharyngeal cancer. For lesions that are locally advanced, the
appropriate use of adjuvant treatment modalities such as postop-
erative radiation therapy remains an important consideration.
Advances in diagnostic techniques and therapies have paved the
way for surgeons to approach lesions using new strategies. Finally,
credit should be given to the ingenuity of surgeons who were
willing to break away from traditional concepts and set new
paradigms that ultimately benefited patients.
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